PTC Therapeutics Raises FY2026 Sales Guidance from $700.000M-$800.000M to $1.080B-$1.180B vs $1.013B Est
Benzinga Newsdesk 5 months ago
NewsGuidance
PTC Therapeutics (NASDAQ:PTCT) raises FY2026 sales outlook from $700.000 million-$800.000 million to $1.080 billion-$1.180 billion vs $1.013 billion estimate.
PTC Therapeutics (NASDAQ:PTCT) raises FY2026 sales outlook from $700.000 million-$800.000 million to $1.080 billion-$1.180 billion vs $1.013 billion estimate.